Non-AIDS-related lymphomatous meningitis: combined modality therapy.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 9409381.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Twenty-two patients (age range, 38 to 69 years; median, 60 years) with lymphomatous meningitis due to metastatic non-AIDS-related non-Hodgkin's lymphoma were treated. Cytologic responses were seen in 16 patients (73%) to first-line chemotherapy, 7 patients (58%) to second-line chemotherapy, and 2 patients (40%) to third-line chemotherapy. Median survival was 10 months (range, 3 to 24 months).
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Lymphoma, Non-Hodgkin
- Meningitis